JDS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J. Dairy Sci. 2009. 92:2477-2484. doi:10.3168/jds.2008-1851
© 2009 American Dairy Science Association ®

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Interpretive Summary
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Freiburghaus, C.
Right arrow Articles by Paulsson, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Freiburghaus, C.
Right arrow Articles by Paulsson, M. A.

Lactoferricin treatment decreases the rate of cell proliferation of a human colon cancer cell line

C. Freiburghaus*,1, B. Janicke*, H. Lindmark-Månsson{dagger}, S. M. Oredsson{ddagger} and M. A. Paulsson*

* Department of Food Technology, Engineering and Nutrition, Lund University, PO Box 124, 22100 Lund, Sweden
{dagger} Swedish Dairy Association, Scheelevägen 17, 22370 Lund, Sweden
{ddagger} Department of Cell and Organism Biology, Lund University, Helgonavägen 3B, 22362 Lund, Sweden

1 Corresponding author: catja.freiburghaus{at}food.lth.se

Food components modify the risk of cancer at a large number of sites but the mechanism of action is unknown. In the present investigation, we studied the effect of the peptide lactoferricin derived from bovine milk lactoferrin on human colon cancer CaCo-2 cells. The cells were either untreated or treated with 2.0, 0.2, or 0.02 µM lactoferricin. Cell cycle kinetics were investigated with a bromodeoxyuridine DNA flow cytometric method. The results show that lactoferricin treatment slightly but significantly prolonged the S phase of the cell cycle. Lactoferricin treatment lowered the level of cyclin E1, a protein involved in the regulation of genes required for G1/S transition and consequently for efficient S phase progression. The slight prolongation of the S phase resulted in a reduction of cell proliferation, which became more apparent after a long treatment time.

Key Words: CaCo-2 • cancer • cell cycle kinetics • lactoferricin







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Dairy Science Association ®.